trending Market Intelligence /marketintelligence/en/news-insights/trending/Ul6B19jnUuTWFajmP1BGXA2 content esgSubNav
In This List

Eloxx Pharmaceuticals names CEO

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Eloxx Pharmaceuticals names CEO

Eloxx Pharmaceuticals Inc. appointed Robert Ward as its chairman and CEO.

Ward succeeds founder and current CEO Silvia Noiman and outgoing Chairman of the Board Robert Heft.

He most recently served as the president and CEO of Radius Health Inc.

Ward brings to Eloxx more than 30 years of experience as a global biopharmaceutical industry leader with experience across the full spectrum of drug development, commercialization and strategic business development transactions, the company said in a statement.